One of the strengths of the HTRIC programme is the collaboration between the Faculty of Science & Engineering and the UMCG, where fundamental scientists work together with clinicians to solve clinical problems. The HTRIC programme will receive 18.4M euros of the total amount for further development.
HTRIC includes research on rapid diagnostics for sepsis, cancer treatments using light, and new methods for visualising infections. The funding will support doctors, technicians, and companies involved in the research.
UMCG-based biobank Acutelines is heavily engaged in sepsis research to improve early recognition of sepsis and develop novel treatments to improve outcome for patients with sepsis.
Acutelines is initiated to improve recognition and treatment of acute diseases and obtain insight in the consequences of acute diseases, including factors predicting its outcome.
Thereby, Acutelines contributes to development of personalized treatment and improves prediction of patient outcomes during and after an acute admission
For more information about Acutelines research data, please visit the UMCG Research Data Catalogue.
